fig2

Figure 2. Serial measurement of bone metabolism markers. (A-C) Markers were measured in serum or urine through the patient’s provider or the UDP (indicated by *). Pre-menopausal (preM) and post-menopausal (postM) reference ranges are provided and values above the reference range are indicated by (H). Measurements made during the time of leuprolide acetate are shown in gray. (B-C) The region between the two dotted lines reflects the reference range for the patient’s age. UDP: Undiagnosed Diseases Program.